Ovid Therapeutics Inc. Annual Return On Assets in % from 2017 to 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Ovid Therapeutics Inc. quarterly/annual Return On Assets history and growth rate from 2017 to 2024.
  • Ovid Therapeutics Inc. Return On Assets for the quarter ending December 31, 2024 was -23.8 %, a 37.7% increase year-over-year.
  • Ovid Therapeutics Inc. annual Return On Assets for 2024 was -23.8 %, a 37.7% increase from 2023.
  • Ovid Therapeutics Inc. annual Return On Assets for 2023 was -38.2 %, a 21.3% decline from 2022.
  • Ovid Therapeutics Inc. annual Return On Assets for 2022 was -31.5 %, a 155% decline from 2021.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2024 -23.8 +14.4 +37.7% Jan 1, 2024 Dec 31, 2024
2023 -38.2 -6.7 -21.3% Jan 1, 2023 Dec 31, 2023
2022 -31.5 -88.8 -155% Jan 1, 2022 Dec 31, 2022
2021 57.3 +175 Jan 1, 2021 Dec 31, 2021
2020 -118 -18.6 -18.7% Jan 1, 2020 Dec 31, 2020
2019 -99.5 -18.1 -22.2% Jan 1, 2019 Dec 31, 2019
2018 -81.4 -5.69 -7.51% Jan 1, 2018 Dec 31, 2018
2017 -75.7 Jan 1, 2017 Dec 31, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.